A New Tool to Assess the Epidemiology of Immune Thrombocytopenia: The Nordic Country Patient Registry for Romiplostim.
作者信息
Moulis Guillaume
机构信息
UMR 1027, Inserm, Université de Toulouse, France.
Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, France.
出版信息
EClinicalMedicine. 2019 Aug 29;14:11-12. doi: 10.1016/j.eclinm.2019.08.011. eCollection 2019 Sep.
Abstract
摘要
相似文献
1
A New Tool to Assess the Epidemiology of Immune Thrombocytopenia: The Nordic Country Patient Registry for Romiplostim.一种评估免疫性血小板减少症流行病学的新工具：罗米司亭北欧国家患者登记处
EClinicalMedicine. 2019 Aug 29;14:11-12. doi: 10.1016/j.eclinm.2019.08.011. eCollection 2019 Sep.
2
Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim.丹麦、瑞典和挪威的慢性免疫性血小板减少症：罗米司亭的北欧国家患者登记处
EClinicalMedicine. 2019 Aug 23;14:80-87. doi: 10.1016/j.eclinm.2019.07.015. eCollection 2019 Sep.
3
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune Thrombocytopenia.利用真实世界数据模拟随机试验的经验教训：以新诊断免疫性血小板减少症的治疗效果为例。
Clin Pharmacol Ther. 2021 Dec;110(6):1570-1578. doi: 10.1002/cpt.2399. Epub 2021 Sep 15.
4
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.罗米司亭治疗儿童免疫性血小板减少症：一项 3 期、随机、双盲、安慰剂对照研究。
Lancet. 2016 Jul 2;388(10039):45-54. doi: 10.1016/S0140-6736(16)00279-8. Epub 2016 Apr 18.
5
Romiplostim.罗米司亭
Cancer Treat Res. 2011;157:267-88. doi: 10.1007/978-1-4419-7073-2_16.
6
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.在常规临床实践中用罗米司亭治疗原发免疫性血小板减少症（ITP）：来自英国 ITP 注册研究的回顾性研究。
Eur J Haematol. 2019 May;102(5):416-423. doi: 10.1111/ejh.13221. Epub 2019 Mar 7.
7
Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation.ITP 患者携带杂合性 MEFV 突变，在罗米司亭治疗期间反复出现疼痛发作。
Int J Hematol. 2023 Feb;117(2):283-286. doi: 10.1007/s12185-022-03453-2. Epub 2022 Sep 23.
8
Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.罗米司亭在一名原发性免疫性血小板减少症血液透析患者中的应用。
Ann Pharmacother. 2012 Nov;46(11):e31. doi: 10.1345/aph.1R134. Epub 2012 Oct 31.
9
Romiplostim-related myelofibrosis in refractory primary immune thrombocytopenia: A Case report.难治性原发性免疫性血小板减少症中与罗米司亭相关的骨髓纤维化：一例报告。
Medicine (Baltimore). 2019 Jun;98(25):e15882. doi: 10.1097/MD.0000000000015882.
10
Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales.在英格兰和威尔士，艾曲泊帕与罗米司亭治疗慢性免疫性血小板减少症的成本效益
Value Health. 2016 Jul-Aug;19(5):614-22. doi: 10.1016/j.jval.2016.03.1856. Epub 2016 May 11.
本文引用的文献
1
Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim.丹麦、瑞典和挪威的慢性免疫性血小板减少症：罗米司亭的北欧国家患者登记处
EClinicalMedicine. 2019 Aug 23;14:80-87. doi: 10.1016/j.eclinm.2019.07.015. eCollection 2019 Sep.
2
Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.基于人群的慢性免疫性血小板减少症患者队列的心血管和出血结局。
J Thromb Haemost. 2019 Jun;17(6):912-924. doi: 10.1111/jth.14446. Epub 2019 Apr 19.
3
Validation of an algorithm identifying incident primary immune thrombocytopenia in the French national health insurance database.验证一种在法国国家健康保险数据库中识别原发性免疫性血小板减少症新发病例的算法。
Eur J Haematol. 2017 Oct;99(4):344-349. doi: 10.1111/ejh.12926. Epub 2017 Aug 22.
4
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.新诊断的成人免疫性血小板减少症：临床流行病学、治疗暴露和演变。CARMEN 多中心前瞻性队列研究结果。
Am J Hematol. 2017 Jun;92(6):493-500. doi: 10.1002/ajh.24702. Epub 2017 Mar 20.
5
[Epidemiology and pharmacoepidemiology of immune thrombocytopenia].[免疫性血小板减少症的流行病学与药物流行病学]
Rev Med Interne. 2017 Jul;38(7):444-449. doi: 10.1016/j.revmed.2016.12.016. Epub 2017 Jan 26.
6
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.免疫性血小板减少症的发病情况：法国全国范围内基于人群的研究。
Blood. 2014 Nov 20;124(22):3308-15. doi: 10.1182/blood-2014-05-578336. Epub 2014 Oct 10.
7
Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.全科医学研究数据库中免疫性血小板减少性紫癜的流行病学
Br J Haematol. 2009 Apr;145(2):235-44. doi: 10.1111/j.1365-2141.2009.07615.x. Epub 2009 Feb 24.
8
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.成人及儿童免疫性血小板减少性紫癜术语、定义及疗效标准的标准化：国际工作组报告
Blood. 2009 Mar 12;113(11):2386-93. doi: 10.1182/blood-2008-07-162503. Epub 2008 Nov 12.
Zotero 插件